Combination of Citalopram and Nortriptyline in the Treatment of Obsessive-Compulsive Disorder: A Double – Blind, Placebo-Controlled Trial
,
Abstract
Objective: The fact that some antidepressants with strong effects on serotonin reuptake blockade fail to relieve obsessive-compulsive symptoms has caused growing interest in investigating noradrenergic function in obsessive-compulsive disorder (OCD) . In light of the above, we undertook a trial to investigate whether the combination of citalopram with nortriptyline is more effective in treating obsessive-compulsive symptoms than citalopram alone.Method: 40 patients who met the DSM-IV criteria for OCD were included in the study. Patients were allocated in a random fashion: 20 patients to citalopram 40mg /day plus nortriptyline 50mg /day, and 20 patients to citalopram 40mg /day plus placebo.
Results: Both protocols significantly decreased the scores of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) over the trial period, but the combination of citalopram and nortriptyline showed a significant superiority over citalopram alone in the treatment of OCD.
Conclusion: As this study indicates, nortriptyline improves the efficacy of citalopram. In addition, a rapid onset of action is one of the advantages of this combination. This study supports further investigation of the noradrenergic– serotonergic hypothesis in OCD.
Horwath E, Weissman MM. Anxiety disorders:epidemiology, In: Sadock BJ, Sadock VA. Comprehensive Textbook of Psychiatry.7nd ed. Philadelphia: Lippincot, William & Willkins; 2000. P.1455-560.
Park LT, Jefferson JW, Greist JH. Obsessive- compulsive disorder: treatment options. CNS Drugs 1997; 3: 187-202.
Marco P, Stefano P, Cesario B, et al. Efficacy of drug treatment in obsessive compulsive disorder: A meta analysis review. British J of Psychiatry 1995; 166: 424-43.
Zohar J, Insel TR, Zohar-Kadouch RC, et al. Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry 1988; 45: 167-72.
Benkelfat C, Murphy DL, Zohar J, et al.Clomipramin in obsessive-compulsive disorder:futher evidence for a serotonergic mechanism of action. Arch Gen Psychiatry 1989; 46: 23-28.
Grest JH, Jefferson JW, Kobak KA, et al. Efficacy& tolerability of serotonin transport inhibitor in obsessive-compulsive disorder: a meta analysis. Arch Gen Psychiatry 1995; 52-6.
Jenike MA, Hyman S, Baer L, et al. A controlled trial of Fluvoxamine in obsessive-compulsive disorder: implications for serotonergic theory. Am J psychiatry 1990; 147: 1209-15.
Hollander E, Fay M, Cohen RN. Serotonergic and noradrenergic sensivity in obsessive-compulsive disorder: behavioral finding. Am J psychiatry 1988; 145: 1015-7.
Reuch SL, O Sullivan RL, Jenike MA. Open treatment of obsessive-compulsive disorder with venlafaxine : a series of ten cases. J clin psychopharmacol 1996; 16: 81-4.
Sveincok H, Uygur B. Venlafaxine open-label treatment of patients with obsessive-compulsive disorder. Aust NZ J psychiatry 2002; 36: 817.
Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Europ J pharmacol 1984; 104: 277-87.
Boleden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic uptake into rat brain synaptospm. Life sci 1993; 52: 1203-29.
Ghassemzade H, Khamseh A, Ebrahimkhani N. Demographic variables and clinical features of obsessive-compulsive disorder in Iran. (In press)
Insel TR, Murphy DL, Cohen RM et al. Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen psychiatry 1983; 40: 605-12.
Zohar J, Insel T. obsessive compulsive disorder: Psychobiological approaches to diagnosis, treatment and pathophysiology. Biol psychiatry 1987;22: 667-87.
Charney DS, Goodman WK, Price LH, et al. Serotonin function in obsessive-compulsive disorder. Arch Gen psychiatry 1988; 45: 177-85.
Jenike MA, Baer L, Greist JH. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side-effects and efficacy. J clin psychopharmaco 1990; 147: 1209-15.
Pigott TA, MT, Bernstein SE. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen psychiatry 1990; 47: 926-32.
Weisler RH, Van Meter S. Rapid onset of antidepressant activity with venlafaxine. J Clin Psychiatry 2002; 63: 534-5.
Brunello N, Mendlewicz J, Kasper S. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol 2002; 12: 461-75.
Noorbala AA, Hosseini SH, Mohammadi MR.Combination of clomipramine and nortriptilyline in the treatment of obsessive-compulsive disorder: a double blind-placebo controlled trial. J of clin Pharm Therap 1998; 23: 155-59.
Raisi F, Nasehi AA. Combination of fluoxetine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial. Med J of the Iran Hospital 2004; 6: 16-20.
Pallanti S, Hollander E, Goodman WK. A qualitative analysis of nonresponse: management of treatment of refractory obsessive-compulsive disorder. J Clin Psychiatry 2004; 65 : s6-s10.
Hollander E, Friedberg J, Wasserman S, et al. Venlafaxine in treatment -resistant obsessive-compulsive disorder. J Clin Psychiatry 2003; 64: 972-976.
Albert U, Aguglia E, Maina G, Bogetto F. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind,12-week,controlled study. J Clin Psychiatry 2002; 63: 149-155.
Phelps NJ, Cates ME. The role of Velafaxine in the treatment of obsessive-compulsive disorder. Ann Pharmacotherapy 2005; 39: 136-40.
Denwis D, Van Megen H J, Westenberg H. A double blind comparison of Venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol 2003; 23: 568-575.
| Files | ||
| Issue | Vol 1 No 2 (2006) | |
| Section | Articles | |
| Keywords | ||
| Citalopram Combination Drug therapy Nortriptyline Obsessive-compulsive disorder | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
